Conference: ACoP 2026
Date: October 11 - 14, 2026
Location: Gaylord National Harbor, Oxon Hill, MD 20745
Booth: 17 & 18
Platinum Sponsor
Honoree: Samer Mouksassi, Certara
Samer Mouksassi will be recognized as a Fellow of the International Society of Pharmacometrics (FISoP) — one of the Society’s highest honors, a career-achievement award for sustained and substantial contributions to the science of pharmacometrics, to ISoP, and to the broader model-informed drug development community. New Fellows are honored during the ACoP opening ceremony.
Where to hear Certara insights and expertise
Workshops:
Room: Chesapeake H
Certara presenters: James Craig, MS, Samer Mouksassi, PhD, Mark Sale, MD
Population PK/PD modeling is the foundation of pharmacometrics. Yet the workflows behind it are slow, technically demanding, and hard to scale. What if the tools got out of the way and let you focus on the science?
In this 3-hour hands-on workshop, Certara’s Phoenix experts introduce two new tools that reimagine how population models are built and run. Both tools rely on the trusted, industry-standard Phoenix NLME engine.
This workshop covers:
- How to build, configure, and simulate population PK/PD models visually in Model Designer — no installation or coding required
- How agentic AI, powered by Phoenix Modeling Assistant (RsNLME’s MCP server), can execute end-to-end modeling workflows from plain-language prompts
- How Model Designer and the workflow agent connect into one reproducible workflow, backed by the Phoenix NLME engine
Room: Chesapeake H
Certara instructors: Joshua F. Apgar and Andrew Matteson, Certara
With hundreds of FDA and EMA submissions now supported by QSP models, quantitative systems pharmacology has come of age — yet most preclinical and clinical programs still aren’t supported by QSP. This workshop unveils Certara IQ™, an environment built to scale QSP from a handful of projects to the entire pipeline. Through worked, practical examples, instructors demonstrate how to apply Certara IQ across four key decision points: new target feasibility, best-in-class properties, first-in-human dose projection, and recommended Phase 2 dose.
Registration:
$450 ACoP Attendees
$300 Students with code STUDENTACOP26
Presentations:
Certara presentation: “Mechanistic Modeling as the Translational Engine: Converting NAM Data into Predictive Human PK/PD and Safety Insights” (11:40 AM – 12:00 PM)
Certara presenter: Piet van der Graaf, Certara
Certara Chair: Samer Mouksassi, Certara (with instructors from AstraZeneca and Eli Lilly)
Certara presenter: Piet van der Graaf, Certara
Certara presentation: Certara contributes “PBPK Models to Medicines” within the session, alongside talks on PBPK in regulatory science and PBPK with AI, and a panel discussion.
Certara presenter: Amin Rostami-Hodjegan, Certara
Certara presentation: “Strengths and Limitations of MBMA as a Tool to Accelerate Drug Development in Rare Diseases” (2:25 – 2:50 PM)
Certara presenter: Matt L. Zierhut, Certara
Certara presentation: “Optimizing PROTACs in Preclinical ADME: From In Vitro Assays to Clinical Translation” (10:30 – 10:50 AM)
Certara presenter: Sibylle Neuhoff, Certara
Certara presentation: “Applications of Real-World Data to MIDD: Insights to Surmount Challenges Gained from Ongoing Research in Alzheimer’s Disease and Pediatric Populations” (3:00 – 3:20 PM)
Certara presenter: Ananth Kadambi, Real World Evidence & Modeling Solutions, Certara
Panel Discussion (4:00 – 4:30 PM) — Certara panelist: Ananth Kadambi.
Chair: Samer Mouksassi, PharmD,PhD,FCP
Presentation within session: Current clinical applications and latest trends in drug development using CUI and other forms of multi-attribute utility approaches- Non-Oncology Case Studies
Presenter: Samer Mouksassi, PharmD,PhD,FCP
Connect with Certara’s scientific and regulatory experts to explore how integrated modeling software and tech-enabled consulting can support confident decision-making across your development program, from early clinical strategy through global submission.
Schedule time with our team at ACoP to discuss your specific challenges and identify practical, model-informed solutions tailored to your program.
Secure your meeting now to ensure dedicated time with our experts onsite.
You May Also Like
From first-in-human trials to global regulatory approvals and post-launch, Certara solutions can help you move your science forward faster, with confidence.
